Patterns of initial disease recurrence after resection of biliary tract cancer

Oncology (Switzerland)

Volumn 83, Issue 2, 2012, Pages 83-90

  Jung, Se Jin ^a   Woo, Sang Myung ^a   Park, Hyung Ki ^a   Lee, Woo Jin ^a   Han, Mi Ah ^a,b   Han, Sung Sik ^a   Kim, Seong Hoon ^a   Park, Sang Jae ^a   Kim, Tae Hyun ^a   Koh, Young Hwan ^a   Hong, Eun Kyung ^a  

^a National Cancer Center   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Adjuvant therapy; Biliary tract cancer; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; BILIARY TRACT DRAINAGE; BILIARY TRACT SURGERY; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CHEMORADIOTHERAPY; CHOLECYSTECTOMY; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; DISTANT METASTASIS; EXTRAHEPATIC CHOLANGIOCARCINOMA; FEMALE; GALLBLADDER CANCER; HUMAN; KIDNEY METASTASIS; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; OVARY METASTASIS; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SKIN METASTASIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT NEOPLASMS; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER NEOPLASMS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TIME FACTORS;

EID: 84863514001     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000339695     Document Type: Article

References (31)

1. Farley DR, Weaver AL, Nagorney DM: 'Natural history' of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995; 70: 425-429.
2. De Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM: Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378.
3. Patel T: Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2: 10.
4. Miyakawa S, Ishihara S, Horiguchi A, Takada T, Miyazaki M, Nagakawa T: Biliary tract cancer treatment: 5,584 results from the biliary tract cancer statistics registry from 1998 to 2004 in japan. J Hepatobiliary Pancreat Surg 2009; 16: 1-7.
5. Serafini FM, Sachs D, Bloomston M, Carey LC, Karl RC, Murr MM, Rosemurgy AS: Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Am Surg 2001; 67: 839-843. (Pubitemid 33738900)
6. Kim S, Kim SW, Bang YJ, Heo DS, Ha SW: Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2002; 54: 414-419. (Pubitemid 35286806)
7. Hughes MA, Frassica DA, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA: Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys 2007; 68: 178-182. (Pubitemid 46589827)
8. Nelson JW, Ghafoori AP, Willett CG, Tyler DS, Pappas TN, Clary BM, Hurwitz HI, Bendell JC, Morse MA, Clough RW, Czito BG: Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2009; 73: 148-153.
9. Jarnagin WR, Klimstra DS, Hezel M, Gonen M, Fong Y, Roggin K, Cymes K, DeMatteo RP, D'Angelica M, Blumgart LH, Singh B: Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 2006; 24: 1152-1160. (Pubitemid 46638813)
10. Yonemoto N, Furuse J, Okusaka T, Yamao K, Funakoshi A, Ohkawa S, Boku N, Tanaka K, Nagase M, Saisho H, Sato T: A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn J Clin Oncol 2007; 37: 843-851. (Pubitemid 350259003)
11. Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD: Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based seer database analysis. J Gastrointest Surg 2007; 11: 1488-1496.
12. Rocha FG, Matsuo K, Blumgart LH, Jarnagin WR: Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Sci 2010; 17: 490-496.
13. Friman S: Cholangiocarcinoma -current treatment options. Scand J Surg 2011; 100: 30-34.
14. Jonas S, Thelen A, Benckert C, Biskup W, Neumann U, Rudolph B, Lopez-Haanninen E, Neuhaus P: Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 2009; 249: 303-309.
15. Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, Macdonald OK, Crane CH, Talamonti MS, Munoz LL, Small W Jr: Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys 2011; 81: 189-198.
16. Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Lillemore KD, Cameron JL: Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 1995; 221: 788-797.
17. Brunner TB, Eccles CL: Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma. Strahlenther Onkol 2010; 186: 672-680.
18. Shiina T, Mikuriya S, Uno T, Toita T, Serizawa S, Itami J, Kawai S, Tani M: Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies. Cancer Chemother Pharmacol 1992; 31(suppl):S115-S118.
19. Shinohara ET, Mitra N, Guo M, Metz JM: Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2008; 72: 1495-1501.
20. Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K: Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 581-587. (Pubitemid 30100635)
21. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y: Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer 2003; 98: 1689-1700. (Pubitemid 37238626)
22. Weber SM, Jarnagin WR, Klimstra D, De- Matteo RP, Fong Y, Blumgart LH: Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193: 384-391. (Pubitemid 32895979)
23. Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, Kusama K, Soeda J, Ogawa S: Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 2006; 41: 893-900. (Pubitemid 44594231)
24. De Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Gamblin TC, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Schulick RD, Choti MA, Gigot JF, Mentha G, Pawlik TM: Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29: 3140-3145.
25. Kobayashi A, Miwa S, Nakata T, Miyagawa S: Disease recurrence patterns after r0 resection of hilar cholangiocarcinoma. Br J Surg 2010; 97: 56-64.
26. Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, Fong Y, DeMatteo RP, Brennan MF, Blumgart LH, Jarnagin WR: Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 2010; 251: 675-681.
27. Kawada K, Taketo MM: Significance and mechanism of lymph node metastasis in cancer progression. Cancer Res 2011; 71: 1214-1218.
28. Briggs CD, Neal CP, Mann CD, Steward WP, Manson MM, Berry DP: Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer 2009; 45: 33-47.
29. Anderson C, Kim R: Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. Cancer Treat Rev 2009; 35: 322-327.
30. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T: Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002; 95: 1685-1695.
31. Yubin L, Chihua F, Zhixiang J, Jinrui O, Zixian L, Jianghua Z, Ye L, Haosheng J, Chaomin L: Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China. Ann Surg Oncol 2008; 15: 2113-2119.